188040 — Bio Port Korea Balance Sheet
0.000.00%
- KR₩62bn
- KR₩65bn
- KR₩73bn
- 69
- 74
- 16
- 54
Annual balance sheet for Bio Port Korea, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | |
---|---|---|
Period Length: | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS |
Status: | Final | Final |
Cash | ||
Cash and Equivalents | ||
Short Term Investments | ||
Cash and Short Term Investments | 7,546 | 11,763 |
Net Total Accounts Receivable | ||
Net Total Receivables | 8,635 | 6,541 |
Total Inventory | ||
Prepaid Expenses | ||
Total Other Current Assets | ||
Total Current Assets | 28,179 | 29,068 |
Gross Property, Plant And Equipment | ||
Accumulated Depreciation | ||
Net Property, Plant And Equipment | 19,346 | 17,682 |
Net Intangible Assets | ||
Long Term Investments | ||
Long Term Notes Receivable | ||
Other Long Term Assets | ||
Total Assets | 49,026 | 48,006 |
Accounts Payable | ||
Accrued Expenses | ||
Notes Payable / Short Term Debt | ||
Current Portion of Long Term Debt / Capital Leases | ||
Total Other Current Liabilities | ||
Total Current Liabilities | 31,238 | 14,290 |
Long Term Debt | ||
Capital Lease Obligations | ||
Total Long Term Debt | ||
Total Debt | ||
Total Other Liabilities | ||
Total Funded Status | ||
Total Liabilities | 34,675 | 19,334 |
Common Stock | ||
Additional Paid In Capital | ||
Retained Earnings (Accumulated Deficit) | ||
Total Equity | 14,351 | 28,672 |
Total Liabilities & Shareholders' Equity | 49,026 | 48,006 |
Total Common Shares Outstanding |